A CODON OPTIMIZED OTOFERLIN AAV DUAL VECTOR GENE THERAPY

作者: Dyka Frank , Hauswirth William

DOI:

关键词:

摘要: Provided herein are methods and compositions for expressing Otoferlin, e.g., utilizing adeno-associated viral (AAV) particles. Further provided of AAV particles comprising one or more polynucleotides encoding Otoferlin codon optimized expression in human cells. Such may be useful treatment diseases disorders such as Deafness, Autosomal Recessive 9 (DFNB9). Also kits compositions.

参考文章(7)
William W. Hauswirth, Sanford Leon Boye, Frank Markus Dyka, Shannon Elizabeth Boye, Dual-AAV Vector-Based Systems and Methods for Delivering Oversized Genes to Mammalian Cells ,(2014)
Stephane Bancel, Tirtha Chakraborty, Antonin De Fougerolles, Susan Whoriskey, None, Modified polynucleotides for treating protein deficiency ,(2014)
Nicholas Muzyczka, Hector Ruben Mendez-Gomez, Engineered receptor/ligand system for delivery of therapeutic agents ,(2016)
Omar Akil, Frank Dyka, Charlotte Calvet, Alice Emptoz, Ghizlene Lahlou, Sylvie Nouaille, Jacques Boutet de Monvel, Jean-Pierre Hardelin, William W. Hauswirth, Paul Avan, Christine Petit, Saaid Safieddine, Lawrence R. Lustig, Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 116, pp. 4496- 4501 ,(2019) , 10.1073/PNAS.1817537116
Federico Mingozzi, Giuseppe Ronzitti, Patrice Vidal, Treatment of glycogen storage disease iii ,(2018)
Sanford L Boye, Frank M Dyka, William W Hauswirth, Akil Omar, COMPOSITIONS AND METHODS FOR EXPRESSING OTOFERLIN ,(2020)